TY  - BOOK
AU  - Giaccone, Giuseppe
AU  - Schilsky, Richard
AU  - Sondel, p. 
TI  - Cancer chemotherapy and biological response modifiers annual 20 / 
SN  - 0444510907
SN  - 0921-4410
U1  - QZ 266 
PY  - 2002///
CY  - Amsterdam : 
PB  - Elsevier, 
KW  - Cancer-Chemotherapy
KW  - Biological Response Modifiers
N1  - Includes Bibliographical references and index; Contents 
Introduction 
I. Drugs 
1. Thymidylates synthase inhibitors 
2. New nucleoside analogue in clinical development 
3. Anthracyclines 
4. Tubulin-targeting agents 
5. Topoisomerase I interactive agents 
6. Topoisomerase II inhibitors 
7. Farnesyltransferase inhibitors 
8. Cyclin-depent kinases as targets for cancer therapy
9. DNA-binding agents 
10. The evolving role of endocrine therapy for the treatment and prevention of breast cancer
11. New targets for cancer chemotherapy

II. Biological Response Modifiers 
12. The graft-versus-turmor effect and escape of malignancy from immune regulation 
13. Donor Lymphocyte infusions for hematopoietic malignancy
14. Diptheria toxin conjugate therapy of cancer
15. Genetical engineered T cells as Adoptive immunotherapy of cancer
16. Integrating IL-12 into therapeutic cancer vaccines
17. Immunotherapy for breast cancer
18. Immunotherapy of Melanoma 
19. CEA loaded dendritic cell vaccines

III. Tumours
20. Lymphomas 
21. Head and neck cancer 
22. Cancers of the large bowel and hepatobiliary track
23. Malignant neuroendocrine tumors 
24. Genitourinary Malignancies 
25. Breast Cancer
26. Advances in the management of melanoma
27. Sarcomas 
28. Brain Tumors
29. Biology and Therapy of Malignant solids tumors in childhood
30. Supportive Care 
31. AIDS - associated malignancies

IV. Special Section - Lung Cancer
32. CT. screening for Lung Cnacer
33. Combined modality treatment of Lung cancer(NSCLC and SCLC)
34. Update on the systemic treatment of lung cancer
35. New targets for the treatment of advanced non-small cell lung cancer
36. Novel Therapies for the treatment of non-small cell lung cancer

ER  -